Canada Pension Plan Investment Board
CMPX icon

Canada Pension Plan Investment Board’s Compass Therapeutics CMPX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Buy
160,900
+135,800
+541% +$401K ﹤0.01% 1397
2026
Q1 		$133K Buy
25,100
+10,200
+68% +$58.9K ﹤0.01% 1624
2025
Q4 		$80K Buy
+14,900
New +$68.8K ﹤0.01% 1845

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Canada Pension Plan Investment Board's CMPX Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Compass Therapeutics (CMPX) stake by 541% in Q2 2026, buying an estimated $401K and bringing the position to 160,900 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Canada Pension Plan Investment Board first reported a position in CMPX in Q4 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Canada Pension Plan Investment Board held 160,900 shares of Compass Therapeutics worth $352K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 135,800 Compass Therapeutics shares in Q2 2026, an estimated $401K.
  • Compass Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1397 holding.
  • Canada Pension Plan Investment Board first reported a position in Compass Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.